Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma.

Michael Fricker from the University of Newcastle, Australia, presents their Original Article published in Allergy:

Follow Allergy on:

Like, share and comment on our videos, thank you.